Bright Ideas - CIN Feasibility Study
ConditionAcute Lymphoblastic Leukemia (ALL)
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age4-18
SponsorThe Hospital for Sick Children
About this trial
In this study investigators will determine the feasibility of a future trial comparing chemotherapy-induced nausea control in children with ALL receiving oral 6-mercaptopurine who do and do not receive problem-solving skill training. This is a novel approach to controlling an important and common treatment-related symptom.
Eligibility criteria
Qualifiers
Age: ≥ 4 years (PeNAT validated in patients 4 to 18 yrs)
newly diagnosed or recurrent disease: first diagnosis of ALL (i.e. non-relapsed) in maintenance therapy
English, French or Spanish-speaking with an English, French or Spanish-speaking guardian (PeNAT available in these languages)
without physical or cognitive impairments that preclude use of the PeNAT
Disqualifiers
None
Trial design
Treatments tested in this trial
- Bright Ideas - CIN Training
Treatment groups
75 Participants
are divided into 1 treatment groupLocations
4Canada
Hospital for Sick ChildrenM5G 1X8, TorontoOntario, Canada
United States
Children's Hospital Los Angeles90027, Los AngelesCalifornia, United States
Rutgers Cancer Institute08901, New BrunswickNew Jersey, United States
Inova Children's Hospital22042, Falls ChurchVirginia, United States
Sponsors and collaborators
The Hospital for Sick Children
Lead sponsor
Rutgers Cancer Institute of New Jersey
Collaborator
Inova Fairfax Hospital
Collaborator
Children's Hospital Los Angeles
Collaborator
Source ClinicalTrials.gov